09 | 김나영 | Covid-19 vaccination and menstrual cycle length in the Apple Womens Health Study |
04 | 김나영 | SNOMED CT: A controlled coded clinical terminology for use in EHRs | |
25 | 정문경 | Statistical methods summary |
27 | 정문경 | Statistical Errors in the Medical Literature (by Frank Harrell) |
01 | 김나영 | Digital medicine and Interoperability |
24 | 정문경 | malnutrition in UKBB |
20 | 정문경 | Google AppSheet | |
20 | 정문경 | Google AppSheet | |
20 | 정문경 | Google AppSheet | |
27 | 김나영 | SMART Markers: Framework for Capturing Patient Generated Digital Endpoints |
08 | 정문경 | CKD cohort in UKBB : CKD diagnosis | |
15 | 김나영 | HL7 FHIR standard-based resource modeling | |
29 | 이시은 | BIg Query Architecture |
04 | Digital signature and blockchain | ||
11 | 정문경 | Exploring CKD cohort in UKBB: Social factors | |
18 | 김나영 | Merging two ontologies_MELLO and PACO |
02 | 이시은 | FHIR and blockchain | |
09 | 조원일 | the model method of PRS scoring | |
09 | 조원일 | the model method of PRS scoring | |
16 | ֿ | Examining polypharmacy in the Korean elderly | |
23 | Health systems with document- or data-element-level data handling | ||
30 | 정문경 | CKD cohort in UKBB |
12 | 김나영 | Creation of eCRF questionnaire |
14 | ֿ | Evaluating risk of problems from Beers Criteria medication combinations | |
21 | Distributed Ledger Technology(DLT) and blockchain | ||
28 | 정문경 | Investigation on Digital Literacy (for Healthcare) |
07 | 안세환 | Compare TPMT haplogroup clusterings | |
14 | ֿ | PhaCT: a novel approach for preemptive PGx testing and medication therapy optimization |
12 | ֿ | Progress in star allele calling for UKBB | |
26 | 안세환 | Introduction of Phylip |
07 | 최선 | Chart review to confirm the results of CDM analysis | |
07 | 최선 | Chart review to confirm the results of CDM analysis | |
14 | 안세환 | The PRISM drug repurposing dataset | |
21 | ֿ | Star allele calling for UKBB |
31 | ֿ | Implementation of pharmacogenomics via a research biobank |
06 | 안세환 | Significant FSGPs estimating FDR | |
20 | ֿ | Properties of the imputed genotype data format BGEN |
06 | ֿ | SWEDEGENE-a Swedish nation-wide DNA sample collection for pharmacogenomic studies of serious adverse drug reactions | |
27 | 안세환 | Fold changes of LINCS L1000 data |
03 | 안세환 | Permutation testing for the distance measures |
06 | ֿ | Clinical Utility of Pharmacogene Panel-Based Testing in Patients Undergoing Percutaneous Coronary Intervention (PCI) | |
13 | ȿ | FAIR data principle | |
20 | 최선 | Query design for EMR study |
02 | 안세환 | L1000 data overview | |
16 | ֿ | Examination of Stargazer through application to 1000 Genomes Project data |
05 | ֿ | Utility of extended Stargazer for calling star alleles with WGS data | |
12 | ȿ | analysis of cpic knowledge resource to build machine readable knowledgebase | |
26 | 최선 | Discussion of Rehabilitation-CDM |
03 | ȿ | Genome data model engine | |
10 | 최선 | Handling missing value in medical dataset | |
17 | 안세환 | Datasets in cBioPortal |
13 | 안세환 | Clinical data for each project in GDM | |
20 | 한봄 | The IMGT/HLA Database | |
27 | ֿ | Linkage disequilibrium between PGx GWAS and candidate SAG variants |
04 | ȿ | Assessment of Diagnostic Usefulness of Liver Fibrosis Predictive Markers | |
11 | 한봄 | Wellcome Trust Protocol about QC | |
25 | 안세환 | About cBioPortal on GDPortal |
11 | ֿ | Progress in troubleshooting of LSPE study error |
07 | ȿ | Assessment of Diagnostic Usefulness of Liver Fibrosis Predictive Markers | |
14 | 최선 | Forest plot | |
21 | 안세환 | How to use cBioPortal in GDPortal |
05 | 정문경 | Avatar Beans: UI for the elderly | |
19 | ֿ | Application of the Large-Scale Population-Level Evidence Generation R package in K-CDM | |
26 | ȿ | Basic exploratory analysis strategies using SQL |
10 | 한봄 | Analysis design considering clinical information | |
17 | 정문경 | Avatar Beans Nutrition - questionnaire design | |
17 | 정문경 | Avatar Beans Nutrition - questionnaire design |
07 | 안세환 | GDM and VVA | |
14 | 정문경 | Research & problems of mHealth technology for CKD | |
21 | 한봄 | Choosing Wisely | |
28 | GDM database and web |
08 | Data importing process of KCDM genome | ||
14 | ֿ | Linking K-CDM to KAERS for active ADE signal detection |
03 | ȿ | K-CDM Genome; panel information | |
23 | KCDM genome and FHIR genomics |
06 | ȿ | Design of K-CDM genome | |
20 | ȿ | [Review] A Realism-Based View on Counts in OMOP | |
20 | ȿ | [Review] A Realism-Based View on Counts in OMOP | |
27 | DNet data import to BioEMR |
18 | New API standard GraphQL |
01 | ȿ | Problems- drug master data structure conversion | |
15 | Open source search engines in CDE search | ||
22 | ȿ | K-CDM ETL Workflow and DB structure review | |
29 | Renewal of Data Workflow from EMR/OCS to XNetHub |
04 | Resource authorization in Apple ResearchKit | ||
18 | Representation of cCDE and constraints in CHMR | ||
25 | Role + Attribute based Access Control in H.A.P |
13 | Structured input,output data through CHMR Sphinx search engine |
16 | ȿ | Computer-aided diagnosis: A survey with bibliometric analysis | |
23 | Database table of resource permission in Healthavatar platform. |
01 | ȫֿ | Healthcare Service | |
08 | ȿ | Current US EMR implementation status review | |
23 | TTA monthly meeting | ||
28 | Ҿƾ eCRF Ȳ |
07 | BMESH browser Ȳ | ||
08 | ǥȸ 12 ȸ ǥڷ | ||
14 | Current process of API implementation | ||
14 | Current process of API implementation | ||
27 | ̼ | K-CDM ETL |
02 | XNet, Avatar Ұ ÿ (APAMI2016) | ||
09 | ̼ | K-CDM ϴ뵥 ETL | |
23 | ȿ | HIRA ó Ž м | |
30 | ȫֿ | PathVisio Review |
01 | MDR ΰǰ | ||
08 | ȫֿ | Developing the Rivaroxaban Surveillance Plan through Mini-Sentinel | |
15 | unknown | ||
22 | CDE Brower ing | ||
22 | ȿ | Phenotype ontologies | |
29 | ̼ | Bisacodyl patient sampling strategy |
07 | New figure for CDE relationships | ||
10 | ȿ | [XNet homepage] Apps FAQ 1 | |
13 | ̼ | HealthAvatar API v4 URI list | |
20 | HealthAvatar API v4 URI list | ||
27 | ȫֿ | Applying SMQs to Adverse Event Data |
03 | MELLO Ʈ Ȳ Ȳ м | ||
07 | MDR vs OpenEHR vs SMART on FHIR | ||
15 | CDE Browser Design | ||
16 | Process of generating Arthronet DEs, eCRFs | ||
21 | ̼ | Development common data model for ADR detection | |
28 | Design of BMeSH Browser |
07 | Uploading canvas image data elements of Arthronet | ||
14 | ȿ | Review:Disrupting Electronic Health Records Systems | |
21 | Avatars Team Review | ||
28 | Extended DEs definition |
09 | PsyBase form Ȳ | ||
17 | Table for extended DEs | ||
24 | Uploading data elements of an ArthroNet CRF | ||
31 | validation ̴ Data Element attribute |
26 | ӽDE (easy Formbuilder) |
08 | Dnet vDE, cDE validation | ||
15 | Easy form builder with search engine(Spinx) |
11 | ȿ | Data analysis; relationship among HIS quality measure constructs in a tertiary hospital | |
19 | ̼ | RS-ADR analysis result |
03 | ̼ | RS-ADR 1.0 update lists | |
04 | CCR/CCD ΰǰ ȯ | ||
10 | de validation Error report | ||
17 | ʽ ƹŸ Ȳ | ||
24 | ȿ | Antibiotic prescribing systems | |
24 | ȿ | Antibiotic prescribing systems | |
29 | TTA_standard for MDR based PHR |
06 | Specific Validation of Composit Variabled DE | ||
13 | Updating AI_C table of CHMR DB | ||
19 | ȣ | DialysisNet |
18 | Design of revised BMESH with DE generating and registering | ||
25 | ̼ | RS-ADRs lab matching plan |
07 | ȭ Ʈ Ȳ | ||
14 | ȿ | Review:Disrupting Electronic Health Records Systems | |
14 | ȿ | Review:Disrupting Electronic Health Records Systems | |
21 | Ʈ Ȳ | ||
28 | Extended DEs definition |
03 | Processing error handling of bioemr | ||
10 | Ŭ Ʈ | ||
17 | ̼ | Evaluation result of RS-ADRs | |
24 | SMART CCDA scorecard | ||
24 | SMART CCDA scorecard | ||
31 | CMO Review by Medical Records Technicians |
08 | Overview of the CCR convertor_1 | ||
15 | BioEMR ߰ ۾ | ||
22 | CMO evaluation result with SNUH clinical note |
24 | ̼ | Statin study overview and progress |
06 | ccr convertor Ȳ | ||
13 | Minor Modification of FamilyHistory and Medication sections in CCR | ||
20 | Result of error handling of BioEMR |
02 | Lab panel info in UMLS LOINC | ||
16 | Automatic Transformation of Data Models with Semantic Annotations | ||
30 | μ | Discussion about validation of RxNorm mapping algorithm |
01 | ȣ | DialysisNet ȸڷ | |
07 | μ | Drug mapping with UMLS(RxNorm) using KPIS in prescription (only single ingredient drugs) | |
21 | Pythonڵ带 CHMR metadata | ||
23 | BioEMR Export(final) | ||
28 | Representation Lab in CCR+ |
10 | Current status of CCR with composite DE | ||
15 | dz Ȳ | ||
16 | LOINC normal range | ||
16 | μ | ڵ ý manual mapping in CCR and KPIS ER schema | |
24 | Medication in CCR with metadata id annotation |
12 | ̰ȭ | Consolidated CDA Review 2 | |
18 | BMESH Ȳ ȹ | ||
20 | Result of extracting nutrition data for researching of lifelog | ||
27 | dz Ȳ |
02 | ̼ | abilify eDW _aripiprazole | |
07 | An offline mobile nutrition monitoring intervention for varying-literacy patients receiving hemodialysis | ||
09 | 1 Է | ||
16 | μ | Example of ingredient column extension |
05 | μ | Web parsing problems on KPIS | |
12 | MELLO with auto completion search function | ||
19 | ̰ȭ | Consolidated CDA review |
07 | ̰ȭ | Diet diary | |
21 | ̼ | ADR Study summary |
01 | ̰ȭ | Organizing Avatar Profile | |
24 | ̼ | MedWatch | |
31 | MELLO items for representing assemble lifelog data |
04 | ̰ȭ | Avatar Diary Designing | |
06 | ȣ | 1 ϰ Ʈ | |
06 | ȸ_ȯڿ DialysisNet | ||
11 | μ | Review of standard codes for prescription contents | |
16 | ȣ | DialysisNet | |
17 | ̼ | ADR ڰ | |
24 | Mapping rules for converting CCR to CCD |
04 | ȣ |
02 | μ | BMESH Metadata Upload | |
10 | ȣ | 1 Ʈ Ȩ | |
16 | ̼ | Ҿƾ Ȯ | |
24 | μ | PUBLIC METADATA(CADSR, USHIK) download and analysis | |
24 | ȣ | 1 Ʈ |
14 | 뷡 | HealthPro last plan | |
14 | HealthAvatar |
04 | ȣ | DialysisNet DB UI 缳 |
12 | ̰ȭ | Desinging of CCR+ UI | |
20 | ȣ | DialysisNet 缳 | |
21 | ̰ȭ | CCR UI design | |
21 | 15 CCR & BioEMR ȸ |
02 | 13 CCR & BioEMR ȸ | ||
16 | Scenario for CCR & Dialysis demonstration including clinical meaning | ||
30 | 14 CCR & BioEMR ȸ | ||
30 | 11 Ź | ||
30 | 뷡 | Demonstration for HealthPro |
06 | CCR & BioEMR 7 Ʈ | ||
06 | 뷡 | HealthPro & Medication | |
06 | DialysisNet app | ||
09 | CCR Ʈ ÿ غ | ||
26 | Dialysis Server | ||
26 | ȣ | Dialysis APP. | |
27 | CCR & BioEMR 8 Ʈ | ||
27 | 7 Ź ǹȸ | ||
27 | 뷡 | HealthPro |
01 | 뷡 | HealthPro DB Schema | |
01 | Ʈ ó - ʱ | ||
11 | CCR & BioEMR 4 Ʈ | ||
11 | ̰ȭ | CCR ȯ | |
15 | 뷡 | Medication | |
29 | 뷡 | Medication RuleSet |
06 | CCR & BioEMR 2 Ʈ | ||
06 | コƹŸ ÷ ó | ||
06 | 뷡 | HealthPro DB Schema | |
13 | ̰ȭ | Patient interest in Sharing Personal Health Record Information. Ann Intern Med 2011 | |
25 | CCR & BioEMR 3 Ʈ | ||
25 | 뷡 | Health Avatar Platform |
02 | Interface design & development of drug contraindication agent | ||
02 | FusionMap : detecting fusion genes from next-generation sequencing data at base-pair resolution | ||
16 | Query design in BMeSH browser |
03 | ̼ | 索 ̿ ADR Study Design | |
17 | CDISC Transformer progress | ||
24 | Health Avatar ó ( ü ) | ||
24 | ̼ | Health Avatar Agent | |
24 | Understanding of RDF | ||
31 | 뷡 | caGrid ġȲ Ȱ |
07 | HealthAvatar CCR | ||
21 | CDISC SDTM Variable mapping rule | ||
29 | Metadata parsing progress | ||
29 | 뷡 | HealthWatch : Online Analysis System Based On Datawarehouse using Healthcare Data. |
02 | The overview of Metamap | ||
09 | 뷡 | BioEMR Technology Transfer |
15 | Signup_Procedure | ||
21 | ̼ | CHMR 3.0 Query performance (Create New Table) | |
28 | CCR Plus App Bugs Report | ||
28 | ̼ | CHMR query optimization |
05 | CHMR_v3_detail | ||
12 | ۿ | CAP cancer protocol | |
12 | CDISC Validator review | ||
19 | Vocabulary based automatic semantic annotator on metadata (Proposal) |
18 | BMESH: Semantic infrastructure | ||
22 | Metadata extraction protocol | ||
25 | Ʈ | ||
29 | ̼ | 2 Ʈ ȹ | |
29 | CHMR Version 3.0 ȹ | ||
29 | 뷡 | BMESH Browser | |
29 | Achieving interoperability between MDRs |
04 | [BioEMR]General form builder [BioEMR] | ||
11 | 赵 | Identification of DKKs target genes [dkk, ǿٱ] | |
19 | GAW data analysis Ȳ |
04 | progress in GTD database - localize CTD | ||
11 | BioEMR Ʈ ȹ ϼ ӻڷ Viewer | ||
18 | 赵 | KMA Drug DB - KMA web interface | |
25 | Progress in GTD database - Parsing localized data for DB input file |
02 | 赵 | Implementation ChromiViz for integration with bioCANDi | |
07 | Research plan (about toxicogenomics meta DB) | ||
14 | Progress in Xperanto-TMA | ||
21 | Progress in GTD database | ||
28 | 赵 | KMA drug DB |
02 | CHMR | ||
09 | Xperanto-Tox: strategy for data modeling toxicogenomics experiment | ||
23 | KMA Drug DB |
05 | Comments and Improvements of proposing method | ||
12 | CHMR Ȳ ȹ | ||
19 | Xperanto-TMA: implementation for applying templates | ||
26 | ڷ ͿϿ콺 պм ý |
04 | Heterogeneous Ensemble | ||
11 | Xperanto-TMA : progress in the "XML Export" function | ||
18 | A Framework for storing various biological material information and functional genomics data | ||
25 | ̿ | affymetrix chip |
07 | ϼ | 2 Ȳ | |
14 | |||
21 | PhactaX ɰ | ||
28 | ̿ | chip |
02 | PhactaManager : ӻڷ | ||
09 | TMA document generator | ||
16 | Xperanto-TMA Ȳ: View κ Vocabulary Է | ||
23 | ISO/IEC 11179 Entity-Attribute-Value ӻڷ | ||
27 | BioEMR Ʈ ? Clinical data storage | ||
30 | 輼 | . |
12 | () | Sample Document RDB NXD | |
16 | BioEMR Ʈ ȹ | ||
19 | BioEMR Ʈ: clinical data storage | ||
26 | BioEMR ȹ( 2 ΰ) |
07 | Ȳ | BioEMR Ʈ ǥ | |
14 | PhactaDictionary (Vocabulary ڵ) | ||
21 | Xperanto-TMA : Test using Real Data | ||
28 | 輼 | Comprehensive Solution to the XMLtoRelational Mapping Problem |
08 | Common Data Element(CDE) (ISO 11179) HL7 Template ֽ | ||
15 | PhactaForm: eCRF Ʈ (Ȳ) | ||
24 | Xperanto-TMA system | ||
31 | Cancer Genomics Object Model |
01 | PhactaForm: eCRF Ʈ | ||
15 | Analysis method review of TMA data for querying Xperanto-TMA | ||
22 | ȭ | ϼ ڷ м ȭ ӻ II |
04 | Object model and database for tissue microarray | ||
11 | PhactaManager(ӻڷý) Ȳ | ||
18 | Cancer Genomics Object Model(2) | ||
25 | ȭ | ϼ ڷ м ȭ ӻ |
06 | ȭ | Plan of Paper submission | |
14 | INFOGENMED : virtual laboratory for accessing and integrating genetic and medical information for health applications | ||
21 | ʱ SNP Է |
09 | ȭ | OCS BtoB | |
16 | An object model and database for biomedical informatics | ||
23 | PhactaDesigner - eCRF design program |
05 | Design of eCRF entry module | ||
26 | ȫ± | ȸ, ȭ, ȿ |
12 | CDA Release 1.0 DTD Integration - second story | ||
19 | Introduction of e-Clinical Trial System |
08 | CDA Release 1.0 DTD Integration | ||
15 | ȭ | Presenting of document constraints for structured discharge note | |
22 | UMLS indexing | ||
29 | ȫ± | Representing clinical guidelines in GLIF |
05 | ȫ± | Review of Guideline | |
12 | ȭ | Relational data in XML (for clinical document processing) | |
19 | Works in progress |
01 | ȫ± | Review of Guideline | |
08 | ȭ | Design of standardized XML DTD for exchange structured discharge note | |
15 | |||
22 | Review of caCORE |
03 | Arden Syntax Arden Syntax Spec | ||
10 | Clinical Trial Registry Systems | ||
15 | ȭ | Schedule of CDA-based Data Structure design | |
17 | Manual indexing and programming | ||
17 | ȫ± | Ƿ New Paradigm | |
24 | Clinical Trial Registry Systems (review of TrialDB) |
06 | ȭ | Design of CDA-based Data Structure | |
06 | ȫ± | , д纴 charting м | |
13 | Mapping free text into UMLS concepts - Progress | ||
13 | About NCI CDE(Common Data Element) | ||
27 | ȫ± | Critical Pathway |